Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
July 16, 2025
Immunology Weekly News – July 16th 2025
July 16, 2025
Neuroscience Weekly News – July 16th 2025
July 15, 2025
Obesity Weekly News – July 15th 2025
July 15, 2025
Endocrinology Weekly Update – July 15th 2025
July 14, 2025
Hematology Weekly News – July 14th 2025
July 14, 2025
Oncology Weekly News – July 14th 2025
July 13, 2025
IAS 2025 Preview: Key HIV Highlights to Watch
July 12, 2025
ENDO 2025 Preview: Endocrinology Highlights to Watch
July 11, 2025
Public Health Weekly News – July 11th 2025
July 11, 2025
Respiratory Weekly News – July 11th 2025
July 11, 2025
Vaccines Weekly Update – July 11th 2025
July 10, 2025